Company page
Transcode Therapeutics, Inc.
Transcode Therapeutics, Inc. is a public company traded under the ticker RNAZ in the American market. The company has a market capitalization of approximately $4.47 million. Transcode focuses on developing innovative therapies in the field of RNA-based treatments.
- Ticker
- RNAZ:NASDAQ
- Asset type
- Stock
- Market cap
- $4.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD